Colgate-Palmolive Company
NYSE:CLHousehold & Personal Products
-$0.71 today
- Market cap
- $78.58B
- Beta
- 0.32
- P/E (TTM)
- 34.5
- EPS (TTM)
- $2.60
- Dividend yield
- 2.33%
Volume 6.07M
Average 5.62M
CL Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Colgate-Palmolive CompanyNYSE: CL
Net Receivables · Q3 FY2026 · quarter ended Sep 2026
Net receivables rises 5.2% from a year ago
Net receivables stood at $1.9B at the end of Q3 FY2026, up 5.2% from a year earlier and down 3.1% from the prior quarter. Over 3 fiscal years it compounded at +3.7% a year.
Context
- Net receivables amounted to 11.4% of total assets at the end of Q3 FY2026, up 1.0 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +5.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 1.68B USD
- Year-over-year change
- +10.1%
- 4-year CAGR
- +6.6%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.68B | +10.1% |
| FY2024 | 2024-12-31 | 1.52B | -4.1% |
| FY2023 | 2023-12-31 | 1.59B | +5.5% |
| FY2022 | 2022-12-31 | 1.5B | +16.0% |
| FY2021 | 2021-12-31 | 1.3B | — |
Net Receivables vs competitors
How CL compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +5.2% is the 3rd highest of 7, against a peer median of +3.5%.
- Net receivables amounts to 11.4% of total assets for CL, versus a peer median of 9.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | €7.67B EUR | +49.9% | +19.1% | 10.9% | |
| Sep 2026 | $6.62B USD | +2.1% | +3.4% | 5.0% | |
| Sep 2026 | $2.5B USD | -15.0% | +7.0% | 9.4% | |
| Sep 2026 | $1.9B USD | +5.2% | +3.7% | 11.4% | |
| Jun 2026 | $1.86B USD | -7.4% | -6.0% | 10.0% | |
| Sep 2026 | $745M USD | +6.0% | +4.8% | 9.5% | |
| Sep 2026 | $635.2M USD | +4.9% | +12.0% | 6.8% | |
| Peer median (excluding CL) | — | +3.5% | +5.9% | 9.5% | |
Competitors are the stored peer set for CL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 832M | 775M | 966M | 1.1B | 1.29B |
| Short-term Investments | 0 | 0 | 0 | 160M | 0 |
| Net Receivables | 1.3B | 1.5B | 1.59B | 1.52B | 1.68B |
| Inventory | 1.69B | 2.07B | 1.93B | 1.99B | 2.03B |
| Other Current Assets | 576M | 760M | 793M | 553M | 714M |
| Total Current Assets | 4.4B | 5.11B | 5.28B | 5.32B | 5.71B |
| Property, Plant & Equipment (Net) | 3.73B | 4.31B | 4.58B | 4.42B | 4.66B |
| Goodwill | 3.28B | 3.35B | 3.41B | 3.27B | 3.12B |
| Intangible Assets | 2.46B | 1.92B | 1.89B | 1.76B | 1.54B |
| Long-term Investments | 0 | 0 | 0 | 81M | 0 |
| Tax Assets | 193M | 135M | 214M | 195M | 205M |
| Other Non-current Assets | 974M | 904M | 1.02B | 1B | 1.1B |
| Total Non-current Assets | 10.64B | 10.62B | 11.11B | 10.73B | 10.62B |
| Total Assets | 15.04B | 15.73B | 16.39B | 16.05B | 16.33B |
| Account Payables | 1.48B | 1.55B | 1.7B | 1.81B | 2.09B |
| Short-term Debt | 51M | 25M | 330M | 660M | 1.12B |
| Tax Payables | 554M | 450M | 503M | 565M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 93M | 97M | 122M | 116M | 118M |
| Total Current Liabilities | 4.05B | 4B | 4.74B | 5.76B | 6.85B |
| Long-term Debt | 7.19B | 8.74B | 8.22B | 7.29B | 6.87B |
| Deferred Tax Liabilities | 395M | 383M | 361M | 343M | 181M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.98B | 1.4B | 1.7B | 1.66B | 1.61B |
| Total Non-current Liabilities | 10.02B | 10.92B | 10.7B | 9.74B | 9.11B |
| Total Liabilities | 14.07B | 14.93B | 15.44B | 15.5B | 15.97B |
| Common Stock | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B |
| Retained Earnings | 24.35B | 24.57B | 25.29B | 26.15B | 26.6B |
| Accumulated OCI | (4.39B) | (4.06B) | (3.94B) | (4.22B) | (3.88B) |
| Other Stockholders Equity | (1M) | (1M) | 0 | 0 | 0 |
| Minority Interest | 362M | 405M | 348M | 332M | 311M |
| Total Equity | 971M | 806M | 957M | 544M | 365M |
| Total Debt | 7.83B | 9.27B | 9.06B | 8.51B | 8.55B |
| Net Debt | 7B | 8.5B | 8.1B | 7.42B | 7.27B |
Colgate-Palmolive Company
NYSE:CL
Intrinsic Alpha fair value
Locked
Current Price
$98.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.